The FDA has scheduled an Oct. 15 meeting of its advisory committee to discuss whether to grant authorization for a booster dose of the J&J vaccine.
Related Articles
-
Pfizer, Moderna say it’s time for another Covid vaccine booster. Experts aren’t sure.
Is it time for yet another Covid-19 booster shot? Pfizer-BioNTech and Moderna seem to think so, but some vaccine...
-
Pfizer asks FDA to authorize Covid antiviral pills
Pfizer asked the Food and Drug Administration on Tuesday to authorize its experimental Covid-19 antiviral treatment, Paxlovid. The treatment...
-
Baby boy born during Hurricane Milton is a ‘miracle’
It was 4 a.m. ET Wednesday when Kenzie Lewellen’s labor began at her home in Port Charlotte, Florida, with...
-
FDA approves drug to protect infants from RSV
IE 11 is not supported. For an optimal experience visit our site on another browser. Mysterious disappearance of Alabama...
-
How to get free or low-cost Covid tests this holiday season — and use them most prudently
A Covid test guide for the holiday season: Tests can expire, but many expiration dates have been extended. New...
-
‘Conspiracy’: China hits back after Biden calls for an investigation into Covid origins
China on Thursday hit back at President Joe Biden’s call to redouble efforts to determine the origins of the...
-
A new version of omicron is gaining a foothold in the U.S., CDC finds
Another omicron subvariant is gaining traction in the United States, the Centers for Disease Control and Prevention reported Tuesday....
-
Hong Kong man becomes first patient to be reinfected with coronavirus, researchers say
A man in Hong Kong has become the first confirmed patient to be infected with the coronavirus a second...
Recent Comments